SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '368'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1AQ7_B_AG2B4_1 (TRYPSINAERUGINOSIN 98-B) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 5 / 8 | HIS A 57ASP A 189SER A 195GLY A 216GLY A 226 | 368 A 901 (-4.0A)368 A 901 (-2.8A)368 A 901 (-1.4A)368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.44A | 1aq7A-1zlrA:33.5 | 1aq7A-1zlrA:39.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1BCU_H_PRLH280_0 (ALPHA-THROMBIN) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 6 / 9 | ASP A 189ALA A 190SER A 195TRP A 215GLY A 216GLY A 226 | 368 A 901 (-2.8A)368 A 901 (-3.7A)368 A 901 (-1.4A)None368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.32A | 1bcuH-1zlrA:35.6 | 1bcuH-1zlrA:37.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1CET_A_CLQA1001_0 (PROTEIN (L-LACTATEDEHYDROGENASE)) |
2g5c | PREPHENATEDEHYDROGENASE (Aquifexaeolicus) | 5 / 9 | VAL A 36GLY A 37ASP A 62ILE A 63GLU A 106 | NoneNAD A3686 (-3.6A)NAD A3686 (-2.8A)NAD A3686 (-3.9A)NAD A3686 ( 4.4A) | 0.76A | 1cetA-2g5cA:9.9 | 1cetA-2g5cA:24.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1DWC_H_MITH1_1 (ALPHA-THROMBIN(LARGE SUBUNIT)) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 5 / 9 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 226 | 368 A 901 (-4.0A)368 A 901 (-2.8A)368 A 901 (-1.4A)None368 A 901 (-3.5A) | 0.28A | 1dwcH-1zlrA:34.9 | 1dwcH-1zlrA:37.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1E9Y_B_HAEB800_1 (UREASE SUBUNIT BETA) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 5 | HIS A 23HIS A 199HIS A 229ASP A 294 | ZN A 367 ( 3.2A) ZN A 368 (-3.1A) ZN A 368 (-3.2A)CAC A 370 (-2.4A) | 0.82A | 1e9yB-3rhgA:15.0 | 1e9yB-3rhgA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EIZ_A_SAMA301_0 (FTSJ) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 12 | GLY A 106PRO A 117GLY A 115GLY A 114LEU A 134 | GDP A1368 (-3.6A)NoneNoneNoneNone | 0.99A | 1eizA-4b46A:4.6 | 1eizA-4b46A:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EJ0_A_SAMA301_0 (FTSJ) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 12 | GLY A 106PRO A 117GLY A 115GLY A 114LEU A 134 | GDP A1368 (-3.6A)NoneNoneNoneNone | 1.00A | 1ej0A-4b46A:undetectable | 1ej0A-4b46A:20.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ETR_H_MITH1_1 (EPSILON-THROMBIN) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 6 / 12 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | 368 A 901 (-4.0A)368 A 901 (-2.8A)368 A 901 (-1.4A)None368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.43A | 1etrH-1zlrA:34.8 | 1etrH-1zlrA:37.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1F5L_A_AMRA301_1 (UROKINASE-TYPEPLASMINOGENACTIVATOR) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 4 / 8 | ASP A 189SER A 195GLY A 216GLY A 226 | 368 A 901 (-2.8A)368 A 901 (-1.4A)368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.43A | 1f5lA-1zlrA:35.2 | 1f5lA-1zlrA:34.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1F9G_A_ASCA950_0 (HYALURONATE LYASE) |
2rjo | TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN (Paraburkholderiaphytofirmans) | 4 / 7 | ASN A 131TRP A 130TYR A 55ARG A 48 | GAL A 368 (-3.7A)GAL A 368 ( 4.0A)SO4 A 370 ( 4.2A)GAL A 368 ( 3.0A) | 1.25A | 1f9gA-2rjoA:undetectable | 1f9gA-2rjoA:19.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1F9G_A_ASCA950_0 (HYALURONATE LYASE) |
2rjo | TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN (Paraburkholderiaphytofirmans) | 4 / 7 | ASN A 131TRP A 130TYR A 55ASN A 183 | GAL A 368 (-3.7A)GAL A 368 ( 4.0A)SO4 A 370 ( 4.2A)GAL A 368 (-4.3A) | 1.47A | 1f9gA-2rjoA:undetectable | 1f9gA-2rjoA:19.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FML_A_RTLA401_0 (RETINOL DEHYDRATASE) |
3zwf | ZINCPHOSPHODIESTERASEELAC PROTEIN 1 (Homosapiens) | 5 / 12 | LEU A 75LEU A 74HIS A 121TYR A 118ILE A 91 | NoneNoneNoneEDO A1368 (-3.5A)None | 1.35A | 1fmlA-3zwfA:undetectable | 1fmlA-3zwfA:21.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FWE_C_HAEC989_1 (UREASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 5 / 6 | HIS A 23HIS A 25HIS A 199HIS A 229ASP A 294 | ZN A 367 ( 3.2A) ZN A 367 ( 3.2A) ZN A 368 (-3.1A) ZN A 368 (-3.2A)CAC A 370 (-2.4A) | 0.80A | 1fweC-3rhgA:15.1 | 1fweC-3rhgA:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GFZ_A_CFFA940_1 (GLYCOGENPHOSPHORYLASE) |
1w85 | PYRUVATEDEHYDROGENASE E1COMPONENT, ALPHASUBUNIT (Geobacillusstearothermophilus) | 4 / 6 | ASN A 202PHE A 266GLY A 269TYR A 268 | MG A1368 ( 2.9A)NoneNoneNone | 0.96A | 1gfzA-1w85A:undetectable | 1gfzA-1w85A:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GXS_A_BEZA601_0 (P-(S)-HYDROXYMANDELONITRILE LYASE CHAINAP-(S)-HYDROXYMANDELONITRILE LYASE CHAINB) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 4 / 7 | GLY A 216ASP A 102HIS A 57ALA A 55 | 368 A 901 (-3.6A)None368 A 901 (-4.0A)None | 1.00A | 1gxsA-1zlrA:undetectable1gxsB-1zlrA:undetectable | 1gxsA-1zlrA:22.021gxsB-1zlrA:19.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HPK_A_ACAA80_1 (PLASMINOGEN) |
5a8q | PUTATIVE RETAININGB-GLYCOSIDASE (Saccharophagusdegradans) | 4 / 6 | PRO A 105ASP A 333ASP A 335TRP A 336 | NoneNoneNoneBGC A1368 (-3.8A) | 1.50A | 1hpkA-5a8qA:undetectable | 1hpkA-5a8qA:9.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ITU_A_CILA451_1 (RENAL DIPEPTIDASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 5 / 12 | TYR A 126GLU A 166HIS A 199HIS A 23ASP A 294 | UNL A 372 (-4.3A) ZN A 368 (-2.5A) ZN A 368 (-3.1A) ZN A 367 ( 3.2A)CAC A 370 (-2.4A) | 1.01A | 1ituA-3rhgA:15.7 | 1ituA-3rhgA:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ITU_B_CILB452_1 (RENAL DIPEPTIDASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 5 / 12 | TYR A 126GLU A 166HIS A 199HIS A 23ASP A 294 | UNL A 372 (-4.3A) ZN A 368 (-2.5A) ZN A 368 (-3.1A) ZN A 367 ( 3.2A)CAC A 370 (-2.4A) | 1.01A | 1ituB-3rhgA:15.8 | 1ituB-3rhgA:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JG2_A_ADNA500_1 (PROTEIN-L-ISOASPARTATEO-METHYLTRANSFERASE) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 12 | GLY A 112GLY A 106LEU A 107GLY A 75VAL A 103 | GDP A1368 (-3.5A)GDP A1368 (-3.6A)NoneNoneNone | 1.19A | 1jg2A-4b46A:undetectable | 1jg2A-4b46A:20.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OE1_A_CUA502_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 3 / 3 | ASP A 294HIS A 229HIS A 23 | CAC A 370 (-2.4A) ZN A 368 (-3.2A) ZN A 367 ( 3.2A) | 0.64A | 1oe1A-3rhgA:undetectable | 1oe1A-3rhgA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OE3_A_CUA502_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 3 / 3 | ASP A 294HIS A 229HIS A 23 | CAC A 370 (-2.4A) ZN A 368 (-3.2A) ZN A 367 ( 3.2A) | 0.65A | 1oe3A-3rhgA:undetectable | 1oe3A-3rhgA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ONI_G_BEZG513_0 (14.5 KDATRANSLATIONALINHIBITOR PROTEIN) |
4auk | RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE M (Escherichiacoli) | 4 / 5 | PHE A 61ARG A 339ILE A 20GLU A 19 | NoneEDO A1368 (-3.5A)NoneNone | 1.48A | 1oniG-4aukA:1.11oniH-4aukA:undetectable | 1oniG-4aukA:15.631oniH-4aukA:15.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6K_A_ACTA860_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 4 / 6 | GLY A 142GLN A 156VAL A 138ALA A 190 | NoneNoneNone368 A 901 (-3.7A) | 0.80A | 1p6kA-1zlrA:undetectable | 1p6kA-1zlrA:19.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PK2_A_ACAA91_1 (TISSUE-TYPEPLASMINOGENACTIVATOR) |
5a8q | PUTATIVE RETAININGB-GLYCOSIDASE (Saccharophagusdegradans) | 4 / 8 | ASP A 333ASP A 335TRP A 336HIS A 107 | NoneNoneBGC A1368 (-3.8A)BGC A1368 (-3.9A) | 1.18A | 1pk2A-5a8qA:undetectable | 1pk2A-5a8qA:15.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RQJ_A_RISA901_1 (GERANYLTRANSTRANSFERASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 11 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.57A | 1rqjA-5ahuB:22.5 | 1rqjA-5ahuB:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RQJ_B_RISB903_1 (GERANYLTRANSTRANSFERASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 11 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.59A | 1rqjB-5ahuB:22.6 | 1rqjB-5ahuB:24.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TNL_A_TPAA900_1 (TRYPSIN) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 4 / 6 | ASP A 189SER A 195GLY A 216GLY A 226 | 368 A 901 (-2.8A)368 A 901 (-1.4A)368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.27A | 1tnlA-1zlrA:33.7 | 1tnlA-1zlrA:39.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLX_A_CIOA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 5 / 12 | HIS A 315LEU A 399THR A 333SER A 368GLN A 369 | HIS A 315 ( 1.0A)LEU A 399 ( 0.6A)THR A 333 ( 0.8A)SER A 368 (-0.0A)GLN A 369 (-0.6A) | 1.31A | 1xlxA-3sl5A:51.0 | 1xlxA-3sl5A:84.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLX_A_CIOA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 12 / 12 | TYR A 159HIS A 160HIS A 204MET A 273LEU A 319ASN A 321THR A 333ILE A 336MET A 337SER A 368GLN A 369PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)HIS A 204 ( 1.0A)MET A 273 (-0.0A)LEU A 319 ( 0.6A)ASN A 321 (-0.6A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)MET A 337 ( 0.0A)SER A 368 (-0.0A)GLN A 369 (-0.6A)PHE A 372 (-1.3A) | 0.54A | 1xlxA-3sl5A:51.0 | 1xlxA-3sl5A:84.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XLX_B_CIOB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 10 / 12 | TYR A 159HIS A 160HIS A 204MET A 273ILE A 336MET A 337PHE A 340MET A 357SER A 368PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)HIS A 204 ( 1.0A)MET A 273 (-0.0A)ILE A 336 ( 0.4A)MET A 337 ( 0.0A)PHE A 340 (-1.3A)MET A 357 (-0.0A)SER A 368 (-0.0A)PHE A 372 (-1.3A) | 0.74A | 1xlxB-3sl5A:51.1 | 1xlxB-3sl5A:84.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XMU_A_ROFA101_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 12 / 12 | TYR A 159HIS A 160ASP A 318LEU A 319PRO A 322TYR A 329TRP A 332ILE A 336PHE A 340MET A 357SER A 368PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)ASP A 318 (-0.5A)LEU A 319 ( 0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)TRP A 332 ( 0.5A)ILE A 336 ( 0.4A)PHE A 340 (-1.3A)MET A 357 (-0.0A)SER A 368 (-0.0A)PHE A 372 (-1.3A) | 0.61A | 1xmuA-3sl5A:51.4 | 1xmuA-3sl5A:84.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XMU_B_ROFB102_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 12 / 12 | TYR A 159HIS A 160MET A 273ASP A 318LEU A 319PRO A 322TYR A 329TRP A 332ILE A 336PHE A 340MET A 357SER A 368 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)ASP A 318 (-0.5A)LEU A 319 ( 0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)TRP A 332 ( 0.5A)ILE A 336 ( 0.4A)PHE A 340 (-1.3A)MET A 357 (-0.0A)SER A 368 (-0.0A) | 0.44A | 1xmuB-3sl5A:51.1 | 1xmuB-3sl5A:84.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOM_A_CIOA603_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 12 / 12 | TYR A 159HIS A 160MET A 273ASP A 318LEU A 319ILE A 336MET A 337PHE A 340MET A 357SER A 368GLN A 369PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)ASP A 318 (-0.5A)LEU A 319 ( 0.6A)ILE A 336 ( 0.4A)MET A 337 ( 0.0A)PHE A 340 (-1.3A)MET A 357 (-0.0A)SER A 368 (-0.0A)GLN A 369 (-0.6A)PHE A 372 (-1.3A) | 0.57A | 1xomA-3sl5A:53.0 | 1xomA-3sl5A:94.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOM_B_CIOB601_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 12 / 12 | TYR A 159HIS A 160MET A 273LEU A 319THR A 333ILE A 336MET A 337PHE A 340MET A 357SER A 368GLN A 369PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)LEU A 319 ( 0.6A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)MET A 337 ( 0.0A)PHE A 340 (-1.3A)MET A 357 (-0.0A)SER A 368 (-0.0A)GLN A 369 (-0.6A)PHE A 372 (-1.3A) | 0.59A | 1xomB-3sl5A:52.8 | 1xomB-3sl5A:94.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 11 / 12 | TYR A 159HIS A 160MET A 273ASP A 318LEU A 319PRO A 322TYR A 329THR A 333ILE A 336MET A 357SER A 368 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)ASP A 318 (-0.5A)LEU A 319 ( 0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)MET A 357 (-0.0A)SER A 368 (-0.0A) | 0.54A | 1xoqA-3sl5A:53.5 | 1xoqA-3sl5A:94.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOQ_A_ROFA502_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 11 / 12 | TYR A 159HIS A 160MET A 273ASP A 318LEU A 319PRO A 322TYR A 329THR A 333ILE A 336SER A 368PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)ASP A 318 (-0.5A)LEU A 319 ( 0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)SER A 368 (-0.0A)PHE A 372 (-1.3A) | 0.52A | 1xoqA-3sl5A:53.5 | 1xoqA-3sl5A:94.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 11 / 12 | TYR A 159HIS A 160ASP A 318LEU A 319PRO A 322TYR A 329TRP A 332THR A 333ILE A 336MET A 357SER A 368 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)ASP A 318 (-0.5A)LEU A 319 ( 0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)TRP A 332 ( 0.5A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)MET A 357 (-0.0A)SER A 368 (-0.0A) | 0.49A | 1xoqB-3sl5A:53.4 | 1xoqB-3sl5A:94.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOQ_B_ROFB501_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 11 / 12 | TYR A 159HIS A 160ASP A 318LEU A 319PRO A 322TYR A 329TRP A 332THR A 333ILE A 336SER A 368PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)ASP A 318 (-0.5A)LEU A 319 ( 0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)TRP A 332 ( 0.5A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)SER A 368 (-0.0A)PHE A 372 (-1.3A) | 0.50A | 1xoqB-3sl5A:53.4 | 1xoqB-3sl5A:94.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOT_A_VDNA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 12 / 12 | TYR A 159HIS A 160MET A 273LEU A 319ILE A 336MET A 337SER A 355MET A 357SER A 368GLN A 369PHE A 372ILE A 376 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)LEU A 319 ( 0.6A)ILE A 336 ( 0.4A)MET A 337 ( 0.0A)SER A 355 ( 0.0A)MET A 357 (-0.0A)SER A 368 (-0.0A)GLN A 369 (-0.6A)PHE A 372 (-1.3A)ILE A 376 (-0.6A) | 0.74A | 1xotA-3sl5A:50.9 | 1xotA-3sl5A:84.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1XOT_B_VDNB102_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 11 / 12 | TYR A 159HIS A 160MET A 273LEU A 319ASN A 321ILE A 336MET A 337SER A 355MET A 357SER A 368PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)LEU A 319 ( 0.6A)ASN A 321 (-0.6A)ILE A 336 ( 0.4A)MET A 337 ( 0.0A)SER A 355 ( 0.0A)MET A 357 (-0.0A)SER A 368 (-0.0A)PHE A 372 (-1.3A) | 0.73A | 1xotB-3sl5A:50.9 | 1xotB-3sl5A:84.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YHL_A_RISA1400_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 11 / 11 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213TYR B 216GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)NoneG76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.53A | 1yhlA-5ahuB:39.9 | 1yhlA-5ahuB:73.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YQ7_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 11 | LEU B 100ARG B 112THR B 217TYR B 216LYS B 269 | NoneG76 B1368 (-2.8A)NoneNoneG76 B1368 (-3.1A) | 1.46A | 1yq7A-5ahuB:32.7 | 1yq7A-5ahuB:33.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YQ7_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 11 / 11 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213TYR B 216GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)NoneG76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.57A | 1yq7A-5ahuB:32.7 | 1yq7A-5ahuB:33.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YV5_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.17A | 1yv5A-5ahuB:33.0 | 1yv5A-5ahuB:33.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YV5_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.46A | 1yv5A-5ahuB:33.0 | 1yv5A-5ahuB:33.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZW5_A_ZOLA901_1 (FARNESYL DIPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.51A | 1zw5A-5ahuB:18.4 | 1zw5A-5ahuB:33.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZW5_A_ZOLA901_1 (FARNESYL DIPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 9 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.16A | 1zw5A-5ahuB:18.4 | 1zw5A-5ahuB:33.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2E91_A_ZOLA901_1 (GERANYLGERANYLPYROPHOSPHATESYNTHETASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 6 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212LYS B 278 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A) MG B1369 (-3.6A) | 1.24A | 2e91A-5ahuB:22.0 | 2e91A-5ahuB:21.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2E91_A_ZOLA901_1 (GERANYLGERANYLPYROPHOSPHATESYNTHETASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 8 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A) | 0.53A | 2e91A-5ahuB:22.0 | 2e91A-5ahuB:21.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2E91_B_ZOLB902_1 (GERANYLGERANYLPYROPHOSPHATESYNTHETASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 6 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212LYS B 278 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A) MG B1369 (-3.6A) | 1.27A | 2e91B-5ahuB:22.2 | 2e91B-5ahuB:21.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2E91_B_ZOLB902_1 (GERANYLGERANYLPYROPHOSPHATESYNTHETASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 8 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A) | 0.61A | 2e91B-5ahuB:22.2 | 2e91B-5ahuB:21.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F89_F_210F9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 9 | ASP B 103ASP B 107ARG B 112LYS B 212THR B 213TYR B 216GLN B 252ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)NoneG76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.31A | 2f89F-5ahuB:16.6 | 2f89F-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F89_F_210F9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 9 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.18A | 2f89F-5ahuB:16.6 | 2f89F-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F8C_F_ZOLF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 11 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.16A | 2f8cF-5ahuB:16.8 | 2f8cF-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F8C_F_ZOLF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 11 | LEU B 100ARG B 112THR B 217TYR B 216LYS B 269 | NoneG76 B1368 (-2.8A)NoneNoneG76 B1368 (-3.1A) | 1.45A | 2f8cF-5ahuB:16.8 | 2f8cF-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F8C_F_ZOLF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 11 / 11 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213TYR B 216GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)NoneG76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.45A | 2f8cF-5ahuB:16.8 | 2f8cF-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F8Z_F_ZOLF5001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.12A | 2f8zF-5ahuB:16.5 | 2f8zF-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F8Z_F_ZOLF5001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.50A | 2f8zF-5ahuB:16.5 | 2f8zF-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F94_F_BFQF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 12 / 12 | LEU B 100ASP B 103ASP B 107ARG B 112THR B 168GLN B 172LYS B 212THR B 213TYR B 216GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)NoneG76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)NoneG76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.46A | 2f94F-5ahuB:17.0 | 2f94F-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2F9K_F_ZOLF9001_1 (FARNESYL DIPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.48A | 2f9kF-5ahuB:15.9 | 2f9kF-5ahuB:33.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HDN_B_TACB1888_1 (ELONGATION FACTOREF-TU) |
3rf7 | IRON-CONTAININGALCOHOLDEHYDROGENASE (Shewanelladenitrificans) | 4 / 5 | THR A 72SER A 119PRO A 157SER A 118 | NoneNoneNonePEG A 368 ( 4.5A) | 1.26A | 2hdnA-3rf7A:undetectable2hdnB-3rf7A:undetectable2hdnD-3rf7A:undetectable | 2hdnA-3rf7A:9.192hdnB-3rf7A:21.052hdnD-3rf7A:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HDN_B_TACB1888_1 (ELONGATION FACTOREF-TU) |
4kqn | D-HYDANTOINASE (Bacillussp.AR9) | 4 / 5 | THR A 87SER A 369PRO A 52SER A 368 | THR A 87 ( 0.8A)SER A 369 ( 0.0A)PRO A 52 ( 1.1A)SER A 368 ( 0.0A) | 1.45A | 2hdnA-4kqnA:undetectable2hdnB-4kqnA:3.22hdnD-4kqnA:3.6 | 2hdnA-4kqnA:7.372hdnB-4kqnA:22.642hdnD-4kqnA:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HDN_D_TACD2888_1 (ELONGATION FACTOREF-TU) |
3rf7 | IRON-CONTAININGALCOHOLDEHYDROGENASE (Shewanelladenitrificans) | 4 / 5 | SER A 118THR A 72SER A 119PRO A 157 | PEG A 368 ( 4.5A)NoneNoneNone | 1.28A | 2hdnB-3rf7A:undetectable2hdnC-3rf7A:undetectable2hdnD-3rf7A:undetectable | 2hdnB-3rf7A:21.052hdnC-3rf7A:9.192hdnD-3rf7A:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HDN_D_TACD2888_1 (ELONGATION FACTOREF-TU) |
4kqn | D-HYDANTOINASE (Bacillussp.AR9) | 4 / 5 | SER A 368THR A 87SER A 369PRO A 52 | SER A 368 ( 0.0A)THR A 87 ( 0.8A)SER A 369 ( 0.0A)PRO A 52 ( 1.1A) | 1.45A | 2hdnB-4kqnA:3.22hdnC-4kqnA:undetectable2hdnD-4kqnA:3.3 | 2hdnB-4kqnA:22.642hdnC-4kqnA:7.372hdnD-4kqnA:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HDN_J_TACJ5888_1 (ELONGATION FACTOREF-TU) |
3rf7 | IRON-CONTAININGALCOHOLDEHYDROGENASE (Shewanelladenitrificans) | 4 / 6 | THR A 72SER A 119PRO A 157SER A 118 | NoneNoneNonePEG A 368 ( 4.5A) | 1.24A | 2hdnI-3rf7A:undetectable2hdnJ-3rf7A:undetectable2hdnL-3rf7A:undetectable | 2hdnI-3rf7A:9.192hdnJ-3rf7A:21.052hdnL-3rf7A:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HDN_L_TACL6888_1 (ELONGATION FACTOREF-TU) |
3rf7 | IRON-CONTAININGALCOHOLDEHYDROGENASE (Shewanelladenitrificans) | 4 / 6 | SER A 118THR A 72SER A 119PRO A 157 | PEG A 368 ( 4.5A)NoneNoneNone | 1.24A | 2hdnJ-3rf7A:undetectable2hdnK-3rf7A:undetectable2hdnL-3rf7A:undetectable | 2hdnJ-3rf7A:21.052hdnK-3rf7A:9.192hdnL-3rf7A:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HKK_A_ALEA300_1 (CARBONIC ANHYDRASE 2) |
3r6y | ASPARTASE (Bacillussp.YM55-1) | 4 / 6 | ASN A 368ILE A 375GLN A 371THR A 37 | ASN A 368 ( 0.6A)ILE A 375 ( 0.7A)GLN A 371 ( 0.6A)THR A 37 ( 0.8A) | 1.26A | 2hkkA-3r6yA:undetectable | 2hkkA-3r6yA:21.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HMY_B_SAMB328_0 (PROTEIN(CYTOSINE-SPECIFICMETHYLTRANSFERASEHHAI)) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 12 | PHE A 167GLY A 135ASN A 169ILE A 186VAL A 228 | NoneNoneGDP A1368 (-3.3A)GDP A1368 (-4.2A)None | 1.02A | 2hmyB-4b46A:4.1 | 2hmyB-4b46A:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2KCE_A_D16A566_2 (THYMIDYLATE SYNTHASE) |
1jof | CARBOXY-CIS,CIS-MUCONATE CYCLASE (Neurosporacrassa) | 3 / 3 | HIS A 3ILE A 336LEU A 26 | BME A 368 (-3.3A)NoneNone | 0.71A | 2kceA-1jofA:undetectable | 2kceA-1jofA:20.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2O1O_A_RISA400_1 (PUTATIVE FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 8 / 9 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) | 0.60A | 2o1oA-5ahuB:13.2 | 2o1oA-5ahuB:24.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2O1O_B_RISB400_1 (PUTATIVE FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 7 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212LYS B 278 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A) MG B1369 (-3.6A) | 0.99A | 2o1oB-5ahuB:14.2 | 2o1oB-5ahuB:24.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2O1O_B_RISB400_1 (PUTATIVE FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 8 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) | 0.63A | 2o1oB-5ahuB:14.2 | 2o1oB-5ahuB:24.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 4 / 6 | ASP A 189SER A 195GLY A 216GLY A 226 | 368 A 901 (-2.8A)368 A 901 (-1.4A)368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.28A | 2otvA-1zlrA:33.9 | 2otvA-1zlrA:39.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OXT_A_SAMA300_0 (NUCLEOSIDE-2'-O-METHYLTRANSFERASE) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 12 | GLY A 114GLY A 12GLY A 9GLY A 110VAL A 104 | NoneNoneGDP A1368 (-3.3A)GDP A1368 (-3.6A)None | 1.04A | 2oxtA-4b46A:undetectable | 2oxtA-4b46A:24.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OXT_D_SAMD300_0 (NUCLEOSIDE-2'-O-METHYLTRANSFERASE) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 6 / 12 | GLY A 142GLY A 42GLY A 196GLY A 193THR A 54LEU A 53 | NoneNoneNone368 A 901 (-3.3A)NoneNone | 1.40A | 2oxtD-1zlrA:undetectable | 2oxtD-1zlrA:22.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2P16_A_GG2A298_1 (COAGULATION FACTOR X(EC 3.4.21.6)(STUART FACTOR)(STUART-PROWERFACTOR)) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 7 / 12 | ASP A 189ALA A 190SER A 195TRP A 215GLY A 216GLY A 226TYR A 228 | 368 A 901 (-2.8A)368 A 901 (-3.7A)368 A 901 (-1.4A)None368 A 901 (-3.6A)368 A 901 (-3.5A)None | 0.37A | 2p16A-1zlrA:35.1 | 2p16A-1zlrA:34.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q58_A_ZOLA1_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 8 / 10 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 256 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A)None | 0.76A | 2q58A-5ahuB:27.1 | 2q58A-5ahuB:24.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q58_A_ZOLA1_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 8 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112LYS B 212THR B 213GLN B 252ASP B 256 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A)None | 0.70A | 2q58A-5ahuB:27.1 | 2q58A-5ahuB:24.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q58_B_ZOLB2_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 6 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212LYS B 278 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A) MG B1369 (-3.6A) | 1.12A | 2q58B-5ahuB:27.3 | 2q58B-5ahuB:24.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q58_B_ZOLB2_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 7 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) | 0.74A | 2q58B-5ahuB:27.3 | 2q58B-5ahuB:24.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QIS_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.18A | 2qisA-5ahuB:32.9 | 2qisA-5ahuB:33.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QIS_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHETASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.48A | 2qisA-5ahuB:32.9 | 2qisA-5ahuB:33.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QMJ_A_ACRA1001_1 (MALTASE-GLUCOAMYLASE, INTESTINAL) |
3zgj | 4-HYDROXYPHENYLPYRUVIC ACID DIOXYGENASE (Streptomycescoelicolor) | 5 / 12 | ASN A 312ILE A 247ILE A 236PHE A 338HIS A 261 | NoneNoneRMN A1369 ( 4.8A)None CO A1368 ( 3.3A) | 1.42A | 2qmjA-3zgjA:undetectable | 2qmjA-3zgjA:18.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2V0Z_O_C41O1327_2 (RENIN) |
2ogs | THERMOSTABLECARBOXYLESTERASEEST50 (Geobacillusstearothermophilus) | 4 / 8 | TYR A 368THR A 367LEU A 225THR A 351 | TYR A 368 ( 1.3A)THR A 367 ( 0.8A)LEU A 225 ( 0.6A)THR A 351 ( 0.8A) | 1.09A | 2v0zO-2ogsA:undetectable | 2v0zO-2ogsA:20.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2VIN_A_505A1247_1 (UROKINASE-TYPEPLASMINOGENACTIVATOR CHAIN B) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 4 / 8 | ASP A 189SER A 195GLY A 216GLY A 226 | 368 A 901 (-2.8A)368 A 901 (-1.4A)368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.39A | 2vinA-1zlrA:10.2 | 2vinA-1zlrA:34.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2W26_A_RIVA1001_1 (ACTIVATED FACTOR XAHEAVY CHAIN) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 8 / 12 | ASP A 189ALA A 190SER A 195TRP A 215GLY A 216GLY A 218GLY A 226TYR A 228 | 368 A 901 (-2.8A)368 A 901 (-3.7A)368 A 901 (-1.4A)None368 A 901 (-3.6A)368 A 901 (-4.3A)368 A 901 (-3.5A)None | 0.43A | 2w26A-1zlrA:35.0 | 2w26A-1zlrA:34.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XXG_A_CUA1338_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 3 / 3 | ASP A 294HIS A 229HIS A 23 | CAC A 370 (-2.4A) ZN A 368 (-3.2A) ZN A 367 ( 3.2A) | 0.66A | 2xxgA-3rhgA:undetectable | 2xxgA-3rhgA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XXG_C_CUC1339_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 3 / 3 | ASP A 294HIS A 229HIS A 23 | CAC A 370 (-2.4A) ZN A 368 (-3.2A) ZN A 367 ( 3.2A) | 0.66A | 2xxgC-3rhgA:undetectable | 2xxgC-3rhgA:21.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YLG_A_ASCA130_0 (CYTOCHROME C') |
2hcm | DUAL SPECIFICITYPROTEIN PHOSPHATASE (Musmusculus) | 4 / 5 | ALA A 104GLY A 98CYH A 95LYS A 96 | NoneNoneNone ZN A 368 (-4.0A) | 1.25A | 2ylgA-2hcmA:undetectable | 2ylgA-2hcmA:23.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YVL_C_SAMC604_1 (HYPOTHETICAL PROTEIN) |
3h4x | PHOSPHATIDYLINOSITOL-SPECIFICPHOSPHOLIPASE C1 (Streptomycesantibioticus) | 4 / 4 | GLY A 141GLU A 144ASP A 146TYR A 213 | ACE A 368 (-3.3A)ACE A 368 (-3.1A)NoneNone | 1.03A | 2yvlC-3h4xA:undetectable | 2yvlC-3h4xA:20.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZUL_A_SAMA376_0 (PROBABLE RIBOSOMALRNA SMALL SUBUNITMETHYLTRANSFERASE) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 12 | GLY A 106GLY A 108ALA A 70VAL A 104VAL A 15 | GDP A1368 (-3.6A)GDP A1368 ( 3.8A)NoneNoneNone | 1.04A | 2zulA-4b46A:3.5 | 2zulA-4b46A:23.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BCR_A_AZZA940_1 (GLYCOGENPHOSPHORYLASE,MUSCLE FORM) |
1w85 | PYRUVATEDEHYDROGENASE E1COMPONENT, ALPHASUBUNIT (Geobacillusstearothermophilus) | 4 / 5 | ASN A 202PHE A 266GLY A 269TYR A 268 | MG A1368 ( 2.9A)NoneNoneNone | 1.02A | 3bcrA-1w85A:undetectable | 3bcrA-1w85A:19.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BUF_A_AEGA394_0 (BETA-SECRETASE 1) |
2g5c | PREPHENATEDEHYDROGENASE (Aquifexaeolicus) | 4 / 5 | ASP A 62ILE A 58ILE A 68GLY A 37 | NAD A3686 (-2.8A)NoneNoneNAD A3686 (-3.6A) | 0.90A | 3bufA-2g5cA:undetectable | 3bufA-2g5cA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DMF_A_SAMA388_0 (PROBABLE RIBOSOMALRNA SMALL SUBUNITMETHYLTRANSFERASE) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 12 | GLY A 106GLY A 108ALA A 70VAL A 104VAL A 15 | GDP A1368 (-3.6A)GDP A1368 ( 3.8A)NoneNoneNone | 1.02A | 3dmfA-4b46A:3.8 | 3dmfA-4b46A:23.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DMH_A_SAMA384_0 (PROBABLE RIBOSOMALRNA SMALL SUBUNITMETHYLTRANSFERASE) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 12 | GLY A 106GLY A 108ALA A 70VAL A 104VAL A 15 | GDP A1368 (-3.6A)GDP A1368 ( 3.8A)NoneNoneNone | 1.02A | 3dmhA-4b46A:2.6 | 3dmhA-4b46A:23.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EEO_A_SAMA328_1 (MODIFICATIONMETHYLASE HHAI) |
2bi3 | PHOSPHOSERINEAMINOTRANSFERASE (Bacillusalcalophilus) | 3 / 3 | GLU A 104SER A 329VAL A 330 | PEG A1368 (-3.5A)NoneNone | 0.79A | 3eeoA-2bi3A:undetectable | 3eeoA-2bi3A:21.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EZ3_A_ZOLA397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.66A | 3ez3A-5ahuB:32.9 | 3ez3A-5ahuB:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EZ3_B_ZOLB397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.55A | 3ez3B-5ahuB:23.5 | 3ez3B-5ahuB:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EZ3_C_ZOLC397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 8 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.67A | 3ez3C-5ahuB:32.9 | 3ez3C-5ahuB:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EZ3_C_ZOLC397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 8 / 9 | ASP B 103ASP B 107ARG B 112LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.48A | 3ez3C-5ahuB:32.9 | 3ez3C-5ahuB:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EZ3_D_ZOLD397_1 (FARNESYLPYROPHOSPHATESYNTHASE, PUTATIVE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.54A | 3ez3D-5ahuB:32.5 | 3ez3D-5ahuB:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FI0_F_TRPF1001_0 (TRYPTOPHANYL-TRNASYNTHETASE) |
2uwf | ALKALINE ACTIVEENDOXYLANASE (Bacillushalodurans) | 5 / 9 | GLN A 291ASP A 360ILE A 359VAL A 351GLN A 12 | None CA A1368 (-3.0A)NoneNoneNone | 1.25A | 3fi0F-2uwfA:undetectable | 3fi0F-2uwfA:21.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 10 / 12 | TYR A 159HIS A 160ASN A 321PRO A 322TYR A 329TRP A 332THR A 333ILE A 336MET A 357SER A 368 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)ASN A 321 (-0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)TRP A 332 ( 0.5A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)MET A 357 (-0.0A)SER A 368 (-0.0A) | 0.52A | 3g4lA-3sl5A:53.4 | 3g4lA-3sl5A:98.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G4L_A_ROFA901_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 11 / 12 | TYR A 159HIS A 160MET A 273ASN A 321PRO A 322TYR A 329TRP A 332THR A 333ILE A 336SER A 368PHE A 372 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)ASN A 321 (-0.6A)PRO A 322 (-1.1A)TYR A 329 (-1.3A)TRP A 332 ( 0.5A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)SER A 368 (-0.0A)PHE A 372 (-1.3A) | 0.44A | 3g4lA-3sl5A:53.4 | 3g4lA-3sl5A:98.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G4L_C_ROFC903_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 3 / 3 | SER A 368GLN A 369PHE A 372 | SER A 368 (-0.0A)GLN A 369 (-0.6A)PHE A 372 (-1.3A) | 0.45A | 3g4lC-3sl5A:53.0 | 3g4lC-3sl5A:98.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G4L_D_ROFD904_0 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
3sl5 | CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D (Homosapiens) | 12 / 12 | TYR A 159HIS A 160MET A 273ASP A 318LEU A 319PRO A 322TRP A 332THR A 333ILE A 336MET A 337SER A 368GLN A 369 | TYR A 159 (-1.3A)HIS A 160 ( 1.0A)MET A 273 (-0.0A)ASP A 318 (-0.5A)LEU A 319 ( 0.6A)PRO A 322 (-1.1A)TRP A 332 ( 0.5A)THR A 333 ( 0.8A)ILE A 336 ( 0.4A)MET A 337 ( 0.0A)SER A 368 (-0.0A)GLN A 369 (-0.6A) | 0.33A | 3g4lD-3sl5A:52.9 | 3g4lD-3sl5A:98.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
5gpr | CHITINASE (Ostriniafurnacalis) | 5 / 12 | VAL A 290SER A 354ILE A 187VAL A 366TYR A 368 | VAL A 290 ( 0.6A)SER A 354 ( 0.0A)ILE A 187 ( 0.7A)VAL A 366 ( 0.6A)TYR A 368 ( 1.3A) | 0.99A | 3g8iA-5gprA:undetectable | 3g8iA-5gprA:20.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GY3_A_PNTA246_0 (CATIONIC TRYPSIN) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 6 / 11 | HIS A 57ASP A 189SER A 195TRP A 215GLY A 216GLY A 226 | 368 A 901 (-4.0A)368 A 901 (-2.8A)368 A 901 (-1.4A)None368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.24A | 3gy3A-1zlrA:12.6 | 3gy3A-1zlrA:39.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3IBA_A_ZOLA901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213TYR B 216GLN B 252ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)NoneG76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.61A | 3ibaA-5ahuB:9.2 | 3ibaA-5ahuB:73.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KP6_B_SALB3008_1 (TRANSCRIPTIONALREGULATOR TCAR) |
1vp6 | CYCLIC-NUCLEOTIDEBINDING DOMAIN OFMESORHIZOBIUM LOTICNG POTASSIUMCHANNEL (Mesorhizobiumloti) | 4 / 7 | GLU A 289VAL A 282VAL A 275ALA A 294 | NoneCMP A 368 (-4.4A)NoneNone | 0.91A | 3kp6B-1vp6A:undetectable | 3kp6B-1vp6A:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LDW_A_ZOLA397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 8 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212GLN B 252ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.71A | 3ldwA-5ahuB:32.8 | 3ldwA-5ahuB:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LDW_A_ZOLA397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 8 / 9 | ASP B 103ASP B 107ARG B 112LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.49A | 3ldwA-5ahuB:32.8 | 3ldwA-5ahuB:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LDW_B_ZOLB397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.57A | 3ldwB-5ahuB:32.6 | 3ldwB-5ahuB:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LDW_C_ZOLC397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.66A | 3ldwC-5ahuB:32.8 | 3ldwC-5ahuB:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LDW_D_ZOLD397_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.57A | 3ldwD-5ahuB:32.6 | 3ldwD-5ahuB:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LSL_G_PZIG801_0 (GLUTAMATE RECEPTOR 2) |
3euc | HISTIDINOL-PHOSPHATEAMINOTRANSFERASE 2 (Cupriaviduspinatubonensis) | 3 / 3 | PRO A 165SER A 303ASN A 167 | NoneNoneSO4 A 368 (-3.4A) | 0.73A | 3lslG-3eucA:0.5 | 3lslG-3eucA:22.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N45_F_ZOLF354_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 11 / 11 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213TYR B 216GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)NoneG76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.49A | 3n45F-5ahuB:16.6 | 3n45F-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N46_F_ZOLF354_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.53A | 3n46F-5ahuB:15.0 | 3n46F-5ahuB:33.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NVC_A_SALA370_1 (GENTISATE1,2-DIOXYGENASE) |
2uwf | ALKALINE ACTIVEENDOXYLANASE (Bacillushalodurans) | 4 / 6 | HIS A 366HIS A 364ARG A 357ASP A 360 | CU A1367 (-3.2A)NoneNone CA A1368 (-3.0A) | 0.99A | 3nvcA-2uwfA:undetectable | 3nvcA-2uwfA:21.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ONN_A_ACTA271_0 (PROTEIN SSM1) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 4 / 5 | GLY A 108GLU A 142GLY A 106PRO A 138 | GDP A1368 ( 3.8A)GDP A1368 (-2.7A)GDP A1368 (-3.6A)GDP A1368 (-4.2A) | 0.96A | 3onnA-4b46A:5.1 | 3onnA-4b46A:23.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RHG_A_BEZA369_0 (PUTATIVEPHOPHOTRIESTERASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 8 / 10 | HIS A 199HIS A 229MET A 254LEU A 257PHE A 261GLU A 264ASP A 294PHE A 296 | ZN A 368 (-3.1A) ZN A 368 (-3.2A)BEZ A 369 ( 3.9A)NoneBEZ A 369 (-4.3A)BEZ A 369 ( 4.4A)CAC A 370 (-2.4A)CAC A 370 (-3.5A) | 0.58A | 3rhgA-3rhgA:70.6 | 3rhgA-3rhgA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RHG_A_BEZA369_0 (PUTATIVEPHOPHOTRIESTERASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 9 / 10 | TYR A 63HIS A 199TRP A 203HIS A 229MET A 254LEU A 257PHE A 261ASP A 294PHE A 296 | UNL A 373 ( 3.6A) ZN A 368 (-3.1A)None ZN A 368 (-3.2A)BEZ A 369 ( 3.9A)NoneBEZ A 369 (-4.3A)CAC A 370 (-2.4A)CAC A 370 (-3.5A) | 0.01A | 3rhgA-3rhgA:70.6 | 3rhgA-3rhgA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RXF_A_4APA9_1 (CATIONIC TRYPSIN) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 4 / 6 | SER A 195TRP A 215GLY A 216GLY A 226 | 368 A 901 (-1.4A)None368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.19A | 3rxfA-1zlrA:13.7 | 3rxfA-1zlrA:39.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SGL_A_SAMA692_0 (TRNA5-METHYLAMINOMETHYL-2-THIOURIDINEBIOSYNTHESISBIFUNCTIONAL PROTEINMNMC) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 12 | GLY A 112GLY A 106ASP A 71VAL A 68GLY A 115 | GDP A1368 (-3.5A)GDP A1368 (-3.6A)NoneNoneNone | 1.06A | 3sglA-4b46A:2.4 | 3sglA-4b46A:19.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T7S_A_SAMA300_0 (PUTATIVEMETHYLTRANSFERASE) |
3tcs | RACEMASE, PUTATIVE (Roseobacterdenitrificans) | 5 / 12 | GLN A 256GLN A 236ASP A 183SER A 118MET A 119 | NoneNone MG A 368 ( 2.7A)NoneDAL A 370 (-3.5A) | 1.27A | 3t7sA-3tcsA:undetectable | 3t7sA-3tcsA:20.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UA1_A_08YA600_1 (CYTOCHROME P450 3A4) |
3ffr | PHOSPHOSERINEAMINOTRANSFERASESERC (Cytophagahutchinsonii) | 5 / 12 | ILE A 316PHE A 287ALA A 323THR A 8ALA A 326 | P33 A 368 ( 4.6A)NoneNoneNoneNone | 0.91A | 3ua1A-3ffrA:undetectable | 3ua1A-3ffrA:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WDM_B_ADNB301_1 (4-PHOSPHOPANTOATE--BETA-ALANINE LIGASE) |
3ulk | KETOL-ACIDREDUCTOISOMERASE (Escherichiacoli) | 5 / 10 | ALA A 363GLY A 368LEU A 432LEU A 371ILE A 295 | ALA A 363 ( 0.0A)GLY A 368 ( 0.0A)LEU A 432 ( 0.5A)LEU A 371 ( 0.5A)ILE A 295 ( 0.6A) | 1.20A | 3wdmB-3ulkA:undetectable | 3wdmB-3ulkA:20.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DR2_A_PARA1609_1 (16S RRNA30S RIBOSOMALPROTEIN S930S RIBOSOMALPROTEIN S10) |
2rjo | TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN (Paraburkholderiaphytofirmans) | 3 / 3 | TYR A 55ARG A 48SER A 49 | SO4 A 370 ( 4.2A)GAL A 368 ( 3.0A)SO4 A 370 (-3.1A) | 1.11A | 4dr2I-2rjoA:1.34dr2J-2rjoA:undetectable | 4dr2I-2rjoA:18.354dr2J-2rjoA:15.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4H9M_A_HAEA929_1 (UREASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 5 | HIS A 23HIS A 199HIS A 229ASP A 294 | ZN A 367 ( 3.2A) ZN A 368 (-3.1A) ZN A 368 (-3.2A)CAC A 370 (-2.4A) | 0.78A | 4h9mA-3rhgA:13.9 | 4h9mA-3rhgA:18.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4HFP_D_15UD402_1 (PROTHROMBIN) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 5 / 12 | HIS A 57ASP A 189ALA A 190TRP A 215GLY A 226 | 368 A 901 (-4.0A)368 A 901 (-2.8A)368 A 901 (-3.7A)None368 A 901 (-3.5A) | 0.22A | 4hfpD-1zlrA:34.6 | 4hfpD-1zlrA:36.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KFA_A_ZOLA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 9 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.54A | 4kfaA-5ahuB:16.1 | 4kfaA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KPD_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.48A | 4kpdA-5ahuB:33.8 | 4kpdA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KPJ_A_210A901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 9 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.23A | 4kpjA-5ahuB:16.4 | 4kpjA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KPJ_A_210A901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 9 | LEU B 100ASP B 103ASP B 107ARG B 112LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.32A | 4kpjA-5ahuB:16.4 | 4kpjA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KQ5_A_ZOLA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.54A | 4kq5A-5ahuB:16.6 | 4kq5A-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KQS_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.20A | 4kqsA-5ahuB:33.7 | 4kqsA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4KQS_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.47A | 4kqsA-5ahuB:33.7 | 4kqsA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9U_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.20A | 4n9uA-5ahuB:15.9 | 4n9uA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9U_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.53A | 4n9uA-5ahuB:15.9 | 4n9uA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9U_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112THR B 168THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)NoneG76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.45A | 4n9uA-5ahuB:15.9 | 4n9uA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4N9U_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112THR B 213 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 (-4.2A) | 1.22A | 4n9uA-5ahuB:15.9 | 4n9uA-5ahuB:30.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NDN_A_SAMA407_0 (S-ADENOSYLMETHIONINESYNTHASE ISOFORMTYPE-2) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 8 | HIS A 229ASP A 253SER A 226SER A 195 | ZN A 368 (-3.2A)NoneNoneNone | 1.20A | 4ndnA-3rhgA:undetectable | 4ndnA-3rhgA:21.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NG6_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 12 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.20A | 4ng6A-5ahuB:18.6 | 4ng6A-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NG6_A_RISA405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 11 / 12 | LEU B 100ASP B 103ASP B 107ARG B 112THR B 168GLN B 172THR B 213TYR B 216GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)NoneG76 B1368 ( 4.1A)G76 B1368 (-4.2A)NoneG76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.53A | 4ng6A-5ahuB:18.6 | 4ng6A-5ahuB:30.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJU_A_TPVA500_2 (PROTEASE) |
2jbw | 2,6-DIHYDROXY-PSEUDO-OXYNICOTINEHYDROLASE (Paenarthrobacternicotinovorans) | 5 / 10 | LEU A 203ALA A 167GLY A 212ILE A 142ILE A 206 | NoneNoneNoneNone NA A1368 (-4.3A) | 1.10A | 4njuB-2jbwA:undetectable | 4njuB-2jbwA:13.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJU_C_TPVC500_2 (PROTEASE) |
2jbw | 2,6-DIHYDROXY-PSEUDO-OXYNICOTINEHYDROLASE (Paenarthrobacternicotinovorans) | 5 / 10 | LEU A 203ALA A 167GLY A 212ILE A 142ILE A 206 | NoneNoneNoneNone NA A1368 (-4.3A) | 1.10A | 4njuD-2jbwA:undetectable | 4njuD-2jbwA:13.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKE_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.23A | 4nkeA-5ahuB:33.1 | 4nkeA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKE_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.54A | 4nkeA-5ahuB:33.1 | 4nkeA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKF_A_210A404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 9 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.23A | 4nkfA-5ahuB:16.6 | 4nkfA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NKF_A_210A404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 9 | LEU B 100ASP B 103ASP B 107ARG B 112LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.36A | 4nkfA-5ahuB:16.6 | 4nkfA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NUA_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.29A | 4nuaA-5ahuB:12.3 | 4nuaA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4NUA_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.58A | 4nuaA-5ahuB:12.3 | 4nuaA-5ahuB:30.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O1E_A_C2FA3000_0 (DIHYDROPTEROATESYNTHASE DHPS) |
2cda | GLUCOSEDEHYDROGENASE (Sulfolobussolfataricus) | 5 / 12 | GLU A 67ASN A 89ILE A 45LEU A 50GLY A 40 | ZN A1368 (-3.1A)NoneNoneNoneNone | 1.08A | 4o1eA-2cdaA:undetectable | 4o1eA-2cdaA:22.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O1E_B_C2FB4000_0 (DIHYDROPTEROATESYNTHASE DHPS) |
2cda | GLUCOSEDEHYDROGENASE (Sulfolobussolfataricus) | 5 / 12 | GLU A 67ASN A 89ILE A 45LEU A 50GLY A 40 | ZN A1368 (-3.1A)NoneNoneNoneNone | 1.10A | 4o1eB-2cdaA:undetectable | 4o1eB-2cdaA:22.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OBW_D_SAMD601_1 (2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOLMETHYLASE,MITOCHONDRIAL) |
2rjo | TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN (Paraburkholderiaphytofirmans) | 3 / 3 | ASN A 131ASP A 105ASP A 266 | GAL A 368 (-3.7A)GAL A 368 (-2.9A)GAL A 368 (-2.9A) | 0.74A | 4obwD-2rjoA:undetectable | 4obwD-2rjoA:20.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OGU_A_210A405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 9 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.22A | 4oguA-5ahuB:17.5 | 4oguA-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OGU_A_210A405_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 9 | LEU B 100ASP B 103ASP B 107ARG B 112LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.32A | 4oguA-5ahuB:17.5 | 4oguA-5ahuB:30.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OLT_A_GCSA303_1 (CHITOSANASE) |
3tcs | RACEMASE, PUTATIVE (Roseobacterdenitrificans) | 4 / 6 | ASP A 183GLY A 234VAL A 255HIS A 207 | MG A 368 ( 2.7A)NoneNoneNone | 1.07A | 4oltA-3tcsA:undetectable | 4oltA-3tcsA:24.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OLT_B_GCSB303_1 (CHITOSANASE) |
3tcs | RACEMASE, PUTATIVE (Roseobacterdenitrificans) | 4 / 6 | ASP A 183GLY A 234VAL A 255HIS A 207 | MG A 368 ( 2.7A)NoneNoneNone | 1.08A | 4oltB-3tcsA:undetectable | 4oltB-3tcsA:24.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P0V_A_ZOLA401_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 9 / 9 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.46A | 4p0vA-5ahuB:16.6 | 4p0vA-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P0W_A_ZOLA501_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 11 | LEU B 100ARG B 112THR B 217TYR B 216LYS B 269 | NoneG76 B1368 (-2.8A)NoneNoneG76 B1368 (-3.1A) | 1.48A | 4p0wA-5ahuB:17.6 | 4p0wA-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4P0W_A_ZOLA501_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 11 / 11 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213TYR B 216GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)NoneG76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.45A | 4p0wA-5ahuB:17.6 | 4p0wA-5ahuB:33.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P6V_E_RBFE201_1 (NA(+)-TRANSLOCATINGNADH-QUINONEREDUCTASE SUBUNIT BNA(+)-TRANSLOCATINGNADH-QUINONEREDUCTASE SUBUNIT E) |
3tcs | RACEMASE, PUTATIVE (Roseobacterdenitrificans) | 4 / 5 | HIS A 207VAL A 231GLU A 209LYS A 145 | NoneNone MG A 368 ( 2.8A)DAL A 370 (-2.9A) | 1.34A | 4p6vB-3tcsA:undetectable4p6vE-3tcsA:undetectable | 4p6vB-3tcsA:23.284p6vE-3tcsA:19.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PAH_A_LNRA600_1 (PHENYLALANINEHYDROXYLASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 6 | LEU A 30HIS A 229HIS A 23GLU A 166 | UNL A 374 ( 3.6A) ZN A 368 (-3.2A) ZN A 367 ( 3.2A) ZN A 368 (-2.5A) | 0.98A | 4pahA-3rhgA:undetectable | 4pahA-3rhgA:20.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PAH_A_LNRA600_1 (PHENYLALANINEHYDROXYLASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 6 | LEU A 297HIS A 229HIS A 23GLU A 166 | None ZN A 368 (-3.2A) ZN A 367 ( 3.2A) ZN A 368 (-2.5A) | 0.96A | 4pahA-3rhgA:undetectable | 4pahA-3rhgA:20.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Q23_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.17A | 4q23A-5ahuB:11.9 | 4q23A-5ahuB:30.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4Q23_A_RISA901_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212TYR B 216GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)NoneG76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.47A | 4q23A-5ahuB:11.9 | 4q23A-5ahuB:30.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QWU_K_BO2K301_1 (PROTEASOME SUBUNITBETA TYPE-5PROTEASOME SUBUNITBETA TYPE-6) |
2rjo | TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN (Paraburkholderiaphytofirmans) | 5 / 9 | ALA A 238THR A 263ALA A 244GLY A 157ASP A 266 | NoneNoneNoneNoneGAL A 368 (-2.9A) | 1.11A | 4qwuK-2rjoA:undetectable4qwuL-2rjoA:undetectable | 4qwuK-2rjoA:20.374qwuL-2rjoA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QWU_Y_BO2Y301_1 (PROTEASOME SUBUNITBETA TYPE-5PROTEASOME SUBUNITBETA TYPE-6) |
2rjo | TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN (Paraburkholderiaphytofirmans) | 5 / 9 | ALA A 238THR A 263ALA A 244GLY A 157ASP A 266 | NoneNoneNoneNoneGAL A 368 (-2.9A) | 1.09A | 4qwuY-2rjoA:undetectable4qwuZ-2rjoA:undetectable | 4qwuY-2rjoA:20.374qwuZ-2rjoA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R7L_A_SHHA709_1 (LEUKOTRIENE A-4HYDROLASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 5 / 12 | HIS A 23GLU A 251HIS A 229GLU A 166LEU A 135 | ZN A 367 ( 3.2A)None ZN A 368 (-3.2A) ZN A 368 (-2.5A)None | 1.06A | 4r7lA-3rhgA:undetectable | 4r7lA-3rhgA:20.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RN6_B_15UB301_1 (THROMBIN HEAVY CHAIN) |
1zlr | COAGULATION FACTORXI (Homosapiens) | 5 / 12 | HIS A 57ALA A 190TRP A 215GLY A 216GLY A 226 | 368 A 901 (-4.0A)368 A 901 (-3.7A)None368 A 901 (-3.6A)368 A 901 (-3.5A) | 0.93A | 4rn6B-1zlrA:29.1 | 4rn6B-1zlrA:36.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RTP_A_SAMA301_0 (DNA ADENINEMETHYLASE) |
2g5c | PREPHENATEDEHYDROGENASE (Aquifexaeolicus) | 5 / 12 | GLY A 39SER A 44ILE A 63ASN A 64PRO A 100 | NAD A3686 (-3.3A)NoneNAD A3686 (-3.9A)NoneNAD A3686 (-4.5A) | 1.15A | 4rtpA-2g5cA:5.6 | 4rtpA-2g5cA:20.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RTS_A_SAMA301_0 (DNA ADENINEMETHYLASE) |
2g5c | PREPHENATEDEHYDROGENASE (Aquifexaeolicus) | 5 / 12 | GLY A 39ASP A 62ILE A 63ASN A 64PRO A 100 | NAD A3686 (-3.3A)NAD A3686 (-2.8A)NAD A3686 (-3.9A)NoneNAD A3686 (-4.5A) | 0.99A | 4rtsA-2g5cA:5.4 | 4rtsA-2g5cA:20.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RXD_A_RISA1404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.20A | 4rxdA-5ahuB:41.7 | 4rxdA-5ahuB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RXD_A_RISA1404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.48A | 4rxdA-5ahuB:41.7 | 4rxdA-5ahuB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RXD_B_RISB1504_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.19A | 4rxdB-5ahuB:19.8 | 4rxdB-5ahuB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RXD_B_RISB1504_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.47A | 4rxdB-5ahuB:19.8 | 4rxdB-5ahuB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RXD_C_RISC1600_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.21A | 4rxdC-5ahuB:41.7 | 4rxdC-5ahuB:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RXD_C_RISC1600_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 10 / 10 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.47A | 4rxdC-5ahuB:41.7 | 4rxdC-5ahuB:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UBP_C_HAEC800_1 (PROTEIN (UREASE(CHAIN C))) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 5 / 6 | HIS A 23HIS A 25HIS A 199HIS A 229ASP A 294 | ZN A 367 ( 3.2A) ZN A 367 ( 3.2A) ZN A 368 (-3.1A) ZN A 368 (-3.2A)CAC A 370 (-2.4A) | 0.65A | 4ubpC-3rhgA:14.9 | 4ubpC-3rhgA:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UCI_B_ADNB2415_1 (RNA-DIRECTED RNAPOLYMERASE L) |
3tcs | RACEMASE, PUTATIVE (Roseobacterdenitrificans) | 4 / 7 | GLU A 209PHE A 205LYS A 145HIS A 207 | MG A 368 ( 2.8A)NoneDAL A 370 (-2.9A)None | 1.28A | 4uciB-3tcsA:undetectable | 4uciB-3tcsA:20.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UMJ_A_BFQA1297_1 (GERANYLTRANSTRANSFERASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 6 / 8 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A) | 0.61A | 4umjA-5ahuB:16.8 | 4umjA-5ahuB:23.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UMJ_B_BFQB1294_1 (GERANYLTRANSTRANSFERASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 7 / 9 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212THR B 213 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A) | 0.51A | 4umjB-5ahuB:9.4 | 4umjB-5ahuB:23.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WG0_C_CHDC102_0 (NUCLEAR RECEPTORCOACTIVATOR 2) |
2we8 | XANTHINEDEHYDROGENASE (Mycolicibacteriumsmegmatis) | 4 / 7 | GLU A 319LEU A 317LEU A 327LEU A 330 | NoneNoneNoneACT A1368 (-4.5A) | 0.75A | 4wg0B-2we8A:undetectable4wg0C-2we8A:undetectable | 4wg0B-2we8A:2.794wg0C-2we8A:2.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WG0_L_CHDL103_0 (NUCLEAR RECEPTORCOACTIVATOR 2) |
2we8 | XANTHINEDEHYDROGENASE (Mycolicibacteriumsmegmatis) | 4 / 7 | LEU A 327LEU A 330GLU A 319LEU A 317 | NoneACT A1368 (-4.5A)NoneNone | 0.77A | 4wg0L-2we8A:undetectable4wg0M-2we8A:undetectable | 4wg0L-2we8A:2.794wg0M-2we8A:2.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X61_A_SAMA701_0 (PROTEIN ARGININEN-METHYLTRANSFERASE5) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 12 | GLY A 135GLY A 106PRO A 138LEU A 137LEU A 164 | NoneGDP A1368 (-3.6A)GDP A1368 (-4.2A)NoneNone | 1.13A | 4x61A-4b46A:undetectable | 4x61A-4b46A:22.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZZC_E_ACTE406_0 (PROTON-GATED IONCHANNEL) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 5 | ILE A 127ILE A 167TYR A 126GLU A 166 | NoneNoneUNL A 372 (-4.3A) ZN A 368 (-2.5A) | 1.05A | 4zzcE-3rhgA:undetectable | 4zzcE-3rhgA:22.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5A1I_A_ADNA407_1 (S-ADENOSYLMETHIONINESYNTHASE ISOFORMTYPE-2) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 8 | HIS A 229ASP A 253SER A 226SER A 195 | ZN A 368 (-3.2A)NoneNoneNone | 1.17A | 5a1iA-3rhgA:undetectable | 5a1iA-3rhgA:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5C0O_G_SAMG301_0 (TRNA(ADENINE(58)-N(1))-METHYLTRANSFERASETRMI) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 12 | ALA A 11GLY A 108GLY A 106GLY A 135ALA A 70 | GDP A1368 (-3.3A)GDP A1368 ( 3.8A)GDP A1368 (-3.6A)NoneNone | 1.00A | 5c0oG-4b46A:3.0 | 5c0oG-4b46A:22.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CG5_A_RISA400_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 12 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.21A | 5cg5A-5ahuB:16.7 | 5cg5A-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CG5_A_RISA400_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 12 / 12 | LEU B 100ASP B 103ASP B 107ARG B 112THR B 168GLN B 172LYS B 212THR B 213TYR B 216GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)NoneG76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)NoneG76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.47A | 5cg5A-5ahuB:16.7 | 5cg5A-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CG6_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 12 | ASP B 107ARG B 112GLN B 252ASP B 255LYS B 269 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 1.18A | 5cg6A-5ahuB:16.8 | 5cg6A-5ahuB:33.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CG6_A_RISA404_1 (FARNESYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 11 / 12 | LEU B 100ASP B 103ASP B 107ARG B 112THR B 168GLN B 172LYS B 212THR B 213GLN B 252ASP B 255LYS B 269 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)NoneG76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 (-4.2A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)G76 B1368 (-3.1A) | 0.47A | 5cg6A-5ahuB:16.8 | 5cg6A-5ahuB:33.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
5l5n | PLEXIN-A4 (Musmusculus) | 3 / 3 | ASP A 368ASN A 363PHE A 357 | ASP A 368 ( 0.5A)ASN A 363 ( 0.6A)PHE A 357 ( 1.3A) | 0.66A | 5dsgB-5l5nA:undetectable | 5dsgB-5l5nA:17.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_A_210A804_1 (FUSICOCCADIENESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 6 / 9 | LEU B 100ASP B 103ARG B 112LYS B 212GLN B 252LYS B 269 | None MG B1370 (-2.5A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A)G76 B1368 (-3.1A) | 1.22A | 5eroA-5ahuB:24.1 | 5eroA-5ahuB:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_A_210A804_1 (FUSICOCCADIENESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 7 / 9 | LEU B 100ASP B 103ASP B 107ARG B 112LYS B 212GLN B 252ASP B 255 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A) | 0.55A | 5eroA-5ahuB:24.1 | 5eroA-5ahuB:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_B_210B804_1 (FUSICOCCADIENESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 6 / 9 | ASP B 103ARG B 112LYS B 212GLN B 252ASP B 256LYS B 269 | MG B1370 (-2.5A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A)NoneG76 B1368 (-3.1A) | 1.17A | 5eroB-5ahuB:23.5 | 5eroB-5ahuB:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_B_210B804_1 (FUSICOCCADIENESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 7 / 9 | ASP B 103ASP B 107ARG B 112LYS B 212GLN B 252ASP B 255ASP B 256 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)None | 0.48A | 5eroB-5ahuB:23.5 | 5eroB-5ahuB:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_B_210B804_1 (FUSICOCCADIENESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 9 | ASP B 107ARG B 112GLN B 252ASP B 255ASP B 256 | MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)None | 1.27A | 5eroB-5ahuB:23.5 | 5eroB-5ahuB:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_C_210C804_1 (FUSICOCCADIENESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 8 / 10 | ASP B 103ASP B 104ASP B 107ARG B 112LYS B 212GLN B 252ASP B 255ASP B 256 | MG B1370 (-2.5A)G76 B1368 ( 4.7A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)None | 0.55A | 5eroC-5ahuB:23.9 | 5eroC-5ahuB:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_C_210C804_1 (FUSICOCCADIENESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 7 / 10 | ASP B 103ASP B 107ARG B 112LYS B 212GLN B 252ASP B 256LYS B 269 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A)NoneG76 B1368 (-3.1A) | 0.93A | 5eroC-5ahuB:23.9 | 5eroC-5ahuB:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_C_210C804_1 (FUSICOCCADIENESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 10 | ASP B 103ASP B 107LYS B 212GLN B 252ASP B 255 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A) | 1.49A | 5eroC-5ahuB:23.9 | 5eroC-5ahuB:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ERO_C_210C804_1 (FUSICOCCADIENESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 6 / 10 | ASP B 107ASP B 104ARG B 112GLN B 252ASP B 255ASP B 256 | MG B1369 (-2.2A)G76 B1368 ( 4.7A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) MG B1371 ( 3.0A)None | 1.29A | 5eroC-5ahuB:23.9 | 5eroC-5ahuB:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JLI_A_ASCA202_0 (CYTOCHROME C') |
2hcm | DUAL SPECIFICITYPROTEIN PHOSPHATASE (Musmusculus) | 4 / 5 | ALA A 104GLY A 98CYH A 95LYS A 96 | NoneNoneNone ZN A 368 (-4.0A) | 1.28A | 5jliA-2hcmA:undetectable | 5jliA-2hcmA:23.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L8D_B_ACTB601_0 (NICKEL-BINDINGPERIPLASMIC PROTEIN) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 3 / 3 | THR A 147PRO A 138ASP A 168 | NoneGDP A1368 (-4.2A)None | 0.59A | 5l8dB-4b46A:undetectable | 5l8dB-4b46A:21.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MWU_B_ACTB601_0 (NICKEL-BINDINGPERIPLASMIC PROTEIN) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 3 / 3 | THR A 147PRO A 138ASP A 168 | NoneGDP A1368 (-4.2A)None | 0.59A | 5mwuB-4b46A:undetectable | 5mwuB-4b46A:21.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5PBE_A_TYLA2001_1 (BROMODOMAIN ADJACENTTO ZINC FINGERDOMAIN PROTEIN 2B) |
5a8j | VWA2 (Sulfolobusacidocaldarius) | 4 / 6 | VAL A 206VAL A 232TYR A 209ASN A 76 | NoneNoneGOL A1368 (-3.0A)None | 0.87A | 5pbeA-5a8jA:undetectable | 5pbeA-5a8jA:16.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VCG_A_08YA602_1 (CYTOCHROME P450 3A4) |
3ffr | PHOSPHOSERINEAMINOTRANSFERASESERC (Cytophagahutchinsonii) | 5 / 12 | ILE A 316PHE A 287ALA A 323THR A 8ALA A 326 | P33 A 368 ( 4.6A)NoneNoneNoneNone | 0.92A | 5vcgA-3ffrA:undetectable | 5vcgA-3ffrA:23.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VLM_H_CVIH301_1 (REGULATORY PROTEINTETR) |
2rjo | TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN (Paraburkholderiaphytofirmans) | 4 / 8 | GLY A 80ILE A 180ASP A 108ASP A 105 | NoneNoneNoneGAL A 368 (-2.9A) | 1.03A | 5vlmH-2rjoA:undetectable | 5vlmH-2rjoA:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIO_A_HFGA801_1 (PROLINE-TRNASYNTHETASE CLASS IIAARS (YBAK RNABINDING DOMAIN PLUSTRNA SYNTHETASE)) |
3fmc | PUTATIVESUCCINYLGLUTAMATEDESUCCINYLASE /ASPARTOACYLASE (Shewanellaamazonensis) | 3 / 3 | THR A 239GLU A 241HIS A 42 | NoneSO4 A 368 ( 4.7A)SO4 A 368 (-4.4A) | 0.91A | 5xioA-3fmcA:undetectable | 5xioA-3fmcA:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y7P_C_CHDC401_0 (BILE SALT HYDROLASE) |
3zgj | 4-HYDROXYPHENYLPYRUVIC ACID DIOXYGENASE (Streptomycescoelicolor) | 4 / 8 | LEU A 358ILE A 236PHE A 233ALA A 263 | RMN A1369 ( 4.1A)RMN A1369 ( 4.8A)None CO A1368 ( 4.4A) | 0.85A | 5y7pC-3zgjA:undetectable | 5y7pC-3zgjA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YOD_H_BEZH201_0 (NS3 PROTEASE) |
5a8q | PUTATIVE RETAININGB-GLYCOSIDASE (Saccharophagusdegradans) | 4 / 5 | HIS A 303SER A 337TYR A 300GLY A 301 | BGC A1366 ( 3.7A)BGC A1368 (-3.5A)NoneNone | 0.83A | 5yodH-5a8qA:undetectable | 5yodH-5a8qA:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZNI_A_YMZA302_0 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
3iau | THREONINE DEAMINASE (Solanumlycopersicum) | 5 / 9 | GLY A 240TYR A 328VAL A 241ASP A 289GLY A 290 | None15P A 368 (-4.7A)NoneNoneNone | 1.34A | 5zniA-3iauA:undetectable | 5zniA-3iauA:11.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6A7P_A_9SCA601_1 (SERUM ALBUMIN) |
2g5c | PREPHENATEDEHYDROGENASE (Aquifexaeolicus) | 4 / 5 | TYR A 61VAL A 87LEU A 34SER A 99 | NAD A3686 (-4.2A)NoneNoneNAD A3686 (-4.6A) | 1.24A | 6a7pA-2g5cA:undetectable | 6a7pA-2g5cA:18.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) |
2we8 | XANTHINEDEHYDROGENASE (Mycolicibacteriumsmegmatis) | 5 / 9 | ILE A 350SER A 306SER A 332SER A 331GLY A 302 | NoneNoneACT A1368 (-4.4A)NoneNone | 1.16A | 6awpA-2we8A:undetectable | 6awpA-2we8A:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B3A_A_SAMA701_0 (APRAMETHYLTRANSFERASE 1) |
2rjo | TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN (Paraburkholderiaphytofirmans) | 5 / 12 | GLY A 292GLY A 61ASP A 105ILE A 129LEU A 291 | NoneNoneGAL A 368 (-2.9A)NoneNone | 1.13A | 6b3aA-2rjoA:2.2 | 6b3aA-2rjoA:19.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B3B_A_SAMA701_0 (APRAMETHYLTRANSFERASE 1) |
2rjo | TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN (Paraburkholderiaphytofirmans) | 5 / 12 | GLY A 292GLY A 61ASP A 105ILE A 129LEU A 291 | NoneNoneGAL A 368 (-2.9A)NoneNone | 1.09A | 6b3bA-2rjoA:2.6 | 6b3bA-2rjoA:19.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DCH_A_ACTA401_0 (SCOE PROTEIN) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 5 | THR A 96HIS A 23ASP A 294HIS A 229 | None ZN A 367 ( 3.2A)CAC A 370 (-2.4A) ZN A 368 (-3.2A) | 1.00A | 6dchA-3rhgA:undetectable | 6dchA-3rhgA:20.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DEB_B_MTXB303_1 (BIFUNCTIONAL PROTEINFOLD) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 4 / 5 | TYR A 183GLN A 180GLY A 112ILE A 136 | GDP A1368 (-3.5A)NoneGDP A1368 (-3.5A)GDP A1368 ( 4.2A) | 1.22A | 6debB-4b46A:2.1 | 6debB-4b46A:12.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_B_TA1B501_2 (TUBULIN BETA CHAIN) |
4mtp | RNA DEPENDENT RNAPOLYMERASE (Japaneseencephalitisvirus) | 4 / 5 | LEU A 640THR A 379PRO A 368ARG A 546 | LEU A 640 ( 0.5A)THR A 379 ( 0.8A)PRO A 368 ( 1.1A)ARG A 546 ( 0.6A) | 1.38A | 6ew0B-4mtpA:undetectable | 6ew0B-4mtpA:7.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_D_TA1D501_2 (TUBULIN BETA CHAIN) |
4mtp | RNA DEPENDENT RNAPOLYMERASE (Japaneseencephalitisvirus) | 4 / 5 | LEU A 640THR A 379PRO A 368ARG A 546 | LEU A 640 ( 0.5A)THR A 379 ( 0.8A)PRO A 368 ( 1.1A)ARG A 546 ( 0.6A) | 1.38A | 6ew0D-4mtpA:undetectable | 6ew0D-4mtpA:7.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_H_TA1H501_2 (TUBULIN BETA CHAIN) |
4mtp | RNA DEPENDENT RNAPOLYMERASE (Japaneseencephalitisvirus) | 4 / 5 | LEU A 640THR A 379PRO A 368ARG A 546 | LEU A 640 ( 0.5A)THR A 379 ( 0.8A)PRO A 368 ( 1.1A)ARG A 546 ( 0.6A) | 1.38A | 6ew0H-4mtpA:undetectable | 6ew0H-4mtpA:7.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_I_TA1I501_2 (TUBULIN BETA CHAIN) |
4mtp | RNA DEPENDENT RNAPOLYMERASE (Japaneseencephalitisvirus) | 4 / 5 | LEU A 640THR A 379PRO A 368ARG A 546 | LEU A 640 ( 0.5A)THR A 379 ( 0.8A)PRO A 368 ( 1.1A)ARG A 546 ( 0.6A) | 1.38A | 6ew0I-4mtpA:undetectable | 6ew0I-4mtpA:7.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FBN_B_SAMB401_1 (S-ADENOSYLMETHIONINESYNTHASE ISOFORMTYPE-2) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 8 | HIS A 229ASP A 253SER A 226SER A 195 | ZN A 368 (-3.2A)NoneNoneNone | 1.13A | 6fbnB-3rhgA:undetectable | 6fbnB-3rhgA:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FBO_A_ADNA406_0 (S-ADENOSYLMETHIONINESYNTHASE ISOFORMTYPE-2) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 8 | HIS A 229ASP A 253SER A 226SER A 195 | ZN A 368 (-3.2A)NoneNoneNone | 1.16A | 6fboA-3rhgA:undetectable | 6fboA-3rhgA:14.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FCB_A_SAMA405_0 (S-ADENOSYLMETHIONINESYNTHASE ISOFORMTYPE-2) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 8 | HIS A 229ASP A 253SER A 226SER A 195 | ZN A 368 (-3.2A)NoneNoneNone | 1.22A | 6fcbA-3rhgA:undetectable | 6fcbA-3rhgA:21.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_A_ZOLA401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 6 / 7 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212GLN B 252 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) | 1.03A | 6g31A-5ahuB:22.8 | 6g31A-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_B_ZOLB401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 6 | ASP B 103ASP B 107ARG B 112GLN B 172GLN B 252 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 ( 4.0A) | 0.76A | 6g31B-5ahuB:23.0 | 6g31B-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_C_ZOLC401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 5 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A) | 1.24A | 6g31C-5ahuB:23.1 | 6g31C-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_D_ZOLD401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 6 / 7 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172GLN B 252 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 ( 4.0A) | 0.65A | 6g31D-5ahuB:23.4 | 6g31D-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_E_ZOLE401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 4 / 4 | LEU B 100ASP B 103ASP B 107ARG B 112 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A) | 0.33A | 6g31E-5ahuB:18.2 | 6g31E-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_F_ZOLF401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 5 / 5 | ASP B 103ASP B 107ARG B 112GLN B 172GLN B 252 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 ( 4.0A) | 0.72A | 6g31F-5ahuB:23.2 | 6g31F-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_G_ZOLG401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 6 / 7 | ASP B 103ASP B 107ARG B 112GLN B 172LYS B 212GLN B 252 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) | 0.59A | 6g31G-5ahuB:21.9 | 6g31G-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_H_ZOLH401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 4 / 5 | ASP B 103ASP B 107GLN B 172GLN B 252 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 ( 4.1A)G76 B1368 ( 4.0A) | 0.70A | 6g31H-5ahuB:22.6 | 6g31H-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_H_ZOLH401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 4 / 5 | ASP B 103ASP B 107GLN B 172LYS B 278 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 ( 4.1A) MG B1369 (-3.6A) | 1.26A | 6g31H-5ahuB:22.6 | 6g31H-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_I_ZOLI401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 4 / 4 | ASP B 103ASP B 107LYS B 212GLN B 252 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.0A) | 0.88A | 6g31I-5ahuB:21.9 | 6g31I-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_J_ZOLJ401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 6 / 6 | LEU B 100ASP B 103ASP B 107ARG B 112GLN B 172GLN B 252 | None MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 ( 4.0A) | 0.95A | 6g31J-5ahuB:23.3 | 6g31J-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_K_ZOLK401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 4 / 4 | ASP B 103ASP B 107ARG B 112GLN B 172 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A) | 0.62A | 6g31K-5ahuB:20.9 | 6g31K-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_L_ZOLL401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) |
5ahu | FARNESYLPYROPHOSPHATESYNTHASE (Trypanosomabrucei) | 6 / 6 | ASP B 103ASP B 107ARG B 112GLN B 172GLN B 252LYS B 278 | MG B1370 (-2.5A) MG B1369 (-2.2A)G76 B1368 (-2.8A)G76 B1368 ( 4.1A)G76 B1368 ( 4.0A) MG B1369 (-3.6A) | 1.12A | 6g31L-5ahuB:22.7 | 6g31L-5ahuB:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MHT_D_SAMD328_0 (CYTOSINE-SPECIFICMETHYLTRANSFERASEHHAI) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 12 | PHE A 167GLY A 135ASN A 169ILE A 186VAL A 228 | NoneNoneGDP A1368 (-3.3A)GDP A1368 (-4.2A)None | 1.10A | 6mhtA-4b46A:3.2 | 6mhtA-4b46A:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6NQA_K_SAMK500_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC) |
4b46 | CELL DIVISIONPROTEIN FTSZ (Haloferaxvolcanii) | 5 / 10 | THR A 111GLY A 65GLY A 59VAL A 68ASN A 38 | GDP A1368 (-4.3A)NoneNoneNoneGDP A1368 ( 4.2A) | 1.42A | 6nqaK-4b46A:undetectable | 6nqaK-4b46A:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6PAH_A_DAHA600_1 (PHENYLALANINE4-MONOOXYGENASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 6 | LEU A 30HIS A 229HIS A 23GLU A 166 | UNL A 374 ( 3.6A) ZN A 368 (-3.2A) ZN A 367 ( 3.2A) ZN A 368 (-2.5A) | 0.97A | 6pahA-3rhgA:undetectable | 6pahA-3rhgA:20.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6PAH_A_DAHA600_1 (PHENYLALANINE4-MONOOXYGENASE) |
3rhg | PUTATIVEPHOPHOTRIESTERASE (Proteusmirabilis) | 4 / 6 | LEU A 297HIS A 229HIS A 23GLU A 166 | None ZN A 368 (-3.2A) ZN A 367 ( 3.2A) ZN A 368 (-2.5A) | 0.99A | 6pahA-3rhgA:undetectable | 6pahA-3rhgA:20.70 |